Categories: News

Avantor® Announces Planned Retirement of Rajiv Gupta, Board Chairman

RADNOR, Pa., Feb. 15, 2022 /PRNewswire/ — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today announced that Rajiv Gupta (76) will retire from Avantor’s Board at the end of his current term and will not stand for re-election at the annual stockholders meeting to be held on May 12, 2022. The Board will announce the selection of a new Board chair later this month.

“On behalf of our entire organization, I want to thank Raj for his vision and guidance in helping to build Avantor into a global life sciences leader,” said Michael Stubblefield, President and CEO of Avantor. “A true business pioneer, Raj has a tremendous track record of value creation and has been a mentor to so many colleagues at Avantor, working tirelessly to position the company for long-term success. We wish him all the best in his future endeavors.”

“It has been an honor serving as Board Chairman of Avantor,” said Rajiv Gupta. “Nearly a dozen years ago I, along with members of New Mountain Capital, set out to build a differentiated life sciences platform that would empower the global scientific community. Today, Avantor is the embodiment of our vision, and I could not be prouder of the positive impact that the company has had on each of its stakeholders. With a superb management team and Board, and a compelling mission, Avantor is well positioned for continued success.”

Gupta has served as Avantor’s Board Chairman since August 2010. He is currently a Senior Advisor to New Mountain Capital, LLC and serves as Board Chairman of Aptiv PLC. Previously, Gupta served as Chairman of Delphi Automotive PLC, from April 2015 to November 2017, when it separated into two companies. For ten years, he served as Chairman and Chief Executive Officer of Rohm and Haas Company, when it was acquired by Dow Chemical. 

More information about Avantor’s board is available at avantorsciences.com.

Avantor
Avantor®, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 225,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. For more information, please visit www.avantorsciences.com and find us on LinkedIn, Twitter and Facebook.

Media Contact
Allison Hosak
Senior Vice President, Global Communications and Brand
Avantor
908-329-7281
Allison.Hosak@avantorsciences.com

Investor Relations Contact
Tommy Thomas, CPA
Vice President, Investor Relations
Avantor
781-375-8051
Tommy.Thomas@avantorsciences.com

View original content:https://www.prnewswire.com/news-releases/avantor-announces-planned-retirement-of-rajiv-gupta-board-chairman-301483101.html

SOURCE Avantor and Financial News

Staff

Recent Posts

Vivos Inc.’s IsoPet® Division Achieves Exceptional Growth in 2024, Expanding Certified Veterinary Clinics Nationwide

Richland, WA, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) is pleased to…

3 hours ago

Assembly Biosciences Reports Interim Phase 1b Results from Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 in Chronic Hepatitis B

– ABI-4334 was well-tolerated with a favorable safety profile and half-life supporting once-daily oral dosing…

3 hours ago

Optinose Announces 1-for-15 Reverse Stock Split

YARDLEY, Pa., Dec. 26, 2024 (GLOBE NEWSWIRE) -- Optinose, Inc. (NASDAQ: OPTN), a pharmaceutical company…

3 hours ago

TScan Therapeutics Announces $30 Million Registered Direct Offering at a 37% Premium

WALTHAM, Mass., Dec. 26, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage…

3 hours ago

Clearmind Medicine Looks to Move Forward with its Novel Psychedelic MEAI- Based Alcohol Substitute

Company recently signed a non-binding term sheet with Dr Glitter Pty Ltd for mutual development…

3 hours ago

SciSparc: AutoMax Announces $13 Million First Delivery of JAC Vehicles Following Regulatory Approval for Direct Importation

TEL AVIV, Israel, Dec. 26, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or…

3 hours ago